Evidence map›Paper›PMID 26201520›Full record

ArticleHepatology international2012

Natural history of HCV infection.

Shiv K Sarin, Manoj Kumar

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Hepatology international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05146609 (Acceptance of Hepatitis C Screening by Self-testing in High Risk and General Population), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05146609 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Acceptance of Hepatitis C Screening by Self-testing in High Risk and General Population

TypeinterventionalSponsorUniversity of La LagunaRan2022 to 2024Enrolled1,384ConditionsHepatitis CArmsScreening HCV. HR-HOSPITAL, Screening HCV. HR-DDP, Screening HCV. GP-HOSPITAL, Screening HCV. GP-PCC
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Animal Models Used in Hepatitis C Virus Research.International journal of molecular sciences · 2020
    Review
  6. Treatment of hepatitis C virus infection in the future.Clinical and translational medicine · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shiv K SarinDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, India. shivsarin@gmail.com.
Manoj KumarDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is much controversy surrounding the natural history of hepatitis C virus (HCV) infection.

aimsThe aim of this review was to review the natural history of HCV infection.

methodsPublished English literature was searched via pubmed and then reviewed.

resultsApproximately, 75-85% of HCV-infected persons will progress to chronic HCV infection. The rate of chronic HCV infection is affected by a person's age, gender, race, and viral immune response. Once chronic HCV infection develops, there are external and host factors that can increase the risk of progression of liver disease. Progression of chronic HCV infection is not linear in time, probably because many cofactors change the rate of development of fibrosis, cirrhosis, and hepatocellular carcinoma. Factors linked with aggressive disease progression include age at infection, duration of infection, heavy alcohol use, co-infections with HIV or hepatitis B virus, male sex, steatosis, insulin resistance (and factors associated with the metabolic syndrome), and host genetics. However, the relative importance of many and varied factors remains uncertain, and further research efforts should be directed toward design of predictive models for effective risk stratification. Interferon-based therapy, particularly among those achieving a sustained virologic response (SVR), is associated with improved fibrosis and inflammation scores, reduced incidence of hepatocellular carcinoma, and prolonged life expectancy.

conclusionsDespite the progress in understanding the factors affecting the natural history of HCV infection, a great deal remains to be learnt.

Indexed as

Acute hepatitis CChronic hepatitis CHepatitis CNatural History

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.